Related Experiment Video
Updated: Sep 12, 2026
Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
Targeting the stroma in pancreatic cancer
Daniel H Ahn1, Ramesh K Ramanathan2
1Department of Hematology/Medical Oncology, Mayo Clinic Cancer Center, Phoenix, AZ, USA.
Abstract:
The tumor stroma in pancreatic adenocarcinoma is recognized as an integral component in tumorigenesis through its effects on cell signaling, immunosuppression and inhibitory effect on therapeutic agents. Promising preclinical activity has been observed with novel therapeutic agents that target the tumor microenvironment and represent one of many potential treatment strategies of interest in this disease. Herein, we will highlight and review therapeutic novel agents aimed at tumor stroma in pancreas cancer.
Insights
Novel therapies targeting the pancreatic cancer tumor stroma show promise. These agents impact tumor microenvironment interactions, offering new treatment avenues for pancreatic adenocarcinoma.
Area of Science:
- Oncology
- Cancer Biology
- Tumor Microenvironment Research
Background:
- The tumor stroma is a critical component of pancreatic adenocarcinoma, influencing tumorigenesis.
- Stroma affects cell signaling, immune suppression, and therapeutic resistance in pancreatic cancer.
- Targeting the tumor microenvironment is a key strategy for pancreatic cancer treatment.
Purpose of the Study:
- To review novel therapeutic agents targeting the tumor stroma in pancreatic cancer.
- To highlight emerging treatment strategies for pancreatic adenocarcinoma.
Main Methods:
- Literature review of preclinical and clinical studies.
- Analysis of therapeutic agents targeting pancreatic cancer stroma.
- Synthesis of current research on tumor microenvironment-based therapies.
Main Results:
- Novel agents targeting pancreatic cancer stroma demonstrate promising preclinical activity.
- These therapies modulate key aspects of the tumor microenvironment.
- Targeting stroma represents a significant area of interest for pancreatic cancer treatment.
Conclusions:
- Therapeutic strategies focused on the pancreatic tumor stroma offer potential for improved outcomes.
- Further investigation and development of these novel agents are warranted.
- Targeting the tumor microenvironment is a viable approach for pancreatic adenocarcinoma.
